NEW PROBLEMS IN THE TREATMENT OF INFECTIOUS DISEASES
Authors: C P MILLER
Journal: Annals of Internal Medicine (1951)

Article1 October 1951NEW PROBLEMS IN THE TREATMENT OF INFECTIOUS DISEASESC. PHILLIP MILLER, M.D., F.A.C.P.C. PHILLIP MILLER, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-35-4-763 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIt may seem a bit like looking a gift horse in the mouth to speak about problems in the treatment of infection when so many of them have already been solved by the recent developments in chemotherapy, developments unparalleled in the whole history of medicine. Nevertheless, new problems have arisen which deserve our attention.Time permits consideration of only three, but they are major problems which have recently become the subject of concern among those responsible for the treatment of infection in our hospitals. The first is the rising incidence of infections caused by drug-resistant bacteria; the second, the increased...Bibliography1. Garrod LP(a) : Acquired bacterial resistance to chemotherapeutic agents, Bull. Hyg. 25: 539, 1950. (b) Miller, C. P., and Bohnhoff, M.: The development of bacterial resistance to chemotherapeutic agents, Ann. Rev. Microbiol. 4: 201, 1950. Google Scholar2. Demerec M: Production of staphylococcus strains resistant to various concentrations of penicillin, Proc. Nat. Acad. Sc. 31: 16, 1945. CrossrefMedlineGoogle Scholar3. MillerBohnhoff CPM: Two streptomycin-resistant variants of meningococcus, J. Bact. 54: 467, 1947. CrossrefMedlineGoogle Scholar4. SpendloveCummingsFacklerMichael GAMMWBM: Enhancement of growth of a strain of Mycobacterium tuberculosis (var. hominis) by streptomycin, Pub. Health Rep. 63: 1177, 1948. CrossrefMedlineGoogle Scholar5. PrattDufrenoy RJ: Antibiotics, 1949, J. B. Lippincott Co., Philadelphia. Google Scholar6. Garrod LP: The reactions of bacteria to chemotherapeutic agents, Brit. M. J. 1: 205, 1951. CrossrefMedlineGoogle Scholar7. SchmithReymann KFE: Experimentelle og kliniske Undersøgelser over Gonococcus Folsomhed overfor Sulfapyridin, Nord. med. tidskr. 8: 2493, 1940. Google Scholar8. JacksonGockeWilcoxFinland GBTMCM: In vitro susceptibility of pneumococcus to seven antibiotics, Am. J. Clin. Path. 20: 218, 1950. CrossrefMedlineGoogle Scholar9. FinlandFrankWilcox MPFC: In vitro susceptibility of pathogenic staphylococci to seven antibiotics, Am. J. Clin. Path. 20: 325, 1950. CrossrefMedlineGoogle Scholar10. BarberRozwadowska-Dowzenko MM: Infection by penicillin-resistant staphylococci, Lancet 2: 641, 1948. CrossrefMedlineGoogle Scholar11. Forbes GB: Infection with penicillin-resistant staphylococci in hospital and general practice, Brit. M. J. 2: 569, 1949. Rountree, P. M., and Thompson, E. F.: Incidence of penicillin-resistant and streptomycin-resistant staphylococci in a hospital, Lancet 2: 501, 1949. CrossrefMedlineGoogle Scholar12. Spink WW(a) : Clinical and biologic significance of penicillin-resistant staphylococci, including observations with streptomycin, aureomycin, chloramphenicol and terramycin, J. Lab. and Clin. Med. 37: 278, 1951. (b) Nichols, D. R., and Needham, G. M.: Aureomycin in the treatment of penicillin resistant staphylococcic bacteremia, Proc. Staff Meet., Mayo Clin. 24: 309, 1949. (c) Beigelman, P. M., and Rantz, L. A.: The clinical importance of coagulase-positive, penicillin-resistant Staphylococcus aureus, New England J. Med. 242: 353, 1950. MedlineGoogle Scholar13. JawetzSpeck ERS(a): Joint action of penicillin with chloramphenicol on an experimental streptococcal infection of mice, Proc. Soc. Exper. Biol. and Med. 74: 93, 1950. (b) Jawetz, E., Gunnison, J. B., Speck, R. S., and Coleman, V. R.: Studies on antibiotic synergism and antagonism; the interference of chloramphenicol with the action of penicillin, Arch. Int. Med. 87: 349, 1951. CrossrefMedlineGoogle Scholar14. Weinstein L: The spontaneous occurrence of new bacterial infections during the course of treatment with streptomycin or penicillin, Am. J. M. Sc. 214: 56, 1947. CrossrefGoogle Scholar15. WoodsManningPatterson JWIHCN: Monilial infections complicating the therapeutic use of antibiotics, J. A. M. A. 145: 207, 1951. CrossrefMedlineGoogle Scholar16. MillerBohnhoff CPM: Effect of streptomycin therapy on the bacterial flora of the throat, Am. J. Med. 6: 417, 1949. CrossrefMedlineGoogle Scholar17. LipmanCossBoots MOJARH: Changes in the bacterial flora of the throat and intestinal tract during prolonged oral administration of penicillin, Am. J. Med. 4: 702, 1948. CrossrefMedlineGoogle Scholar18. Waksman SA: Microbial antagonisms and antibiotic substances, 1945, The Commonwealth Fund, New York. Google Scholar19. ThompsonJohnson RA: The inhibitory action of saliva on the diphtheria bacillus: hydrogen peroxide, the inhibitory agent produced by salivary streptococci, J. Infect. Dis. 88: 81, 1951. CrossrefMedlineGoogle Scholar20. FloreyChainHeatleyJenningsSandersAbrahamFlorey HWENGMAAGEPME: Antibiotics, vol. 1, 1949, Oxford University Press, London. Google Scholar21. Halbert SP: The relation of antagonistic coliform organisms to Shigella infections, II. Observations in acute infections, J. Immunol. 60: 359, 1948. MedlineGoogle Scholar22. MillerHammondTompkins CPCWM: Reduction of mortality from x-radiation by treatment with antibiotics, Science 3: 719, 1950. CrossrefGoogle Scholar23. MillerBohnhoff CPM: Unpublished experiments. Google Scholar24. BeckBrowneJohnsonKennedyMacKenzie JCJSLGBJDW: Occurrence of peritonitis during ACTH administration, Canad. M. A. J. 62: 423, 1950. MedlineGoogle Scholar25. MogabgabThomas WJL: Effects of cortisone on experimental infection with Group A streptococci in rabbits, Central Soc. Clin. Inv. 23: (Nov.) 1950. Google Scholar26. KassIngbarLundgrenFinland EHSHMMM: The effect of ACTH and cortisone on pneumococcal and influenza viral infection in the white mouse, J. Lab. and Clin. Med. 37: 780, 1951. MedlineGoogle Scholar27. BerlinHawk BSWD: Personal communication to the author. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Chicago, Illinois*Presented at the Thirty-second Annual Session of the American College of Physicians, St. Louis, Mo., April 12, 1951.From the Department of Medicine and The Institute of Radiobiology and Biophysics, The University of Chicago. Nextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byVulvovaginitis Caused by Candida Species Following Antibiotic ExposureRetargeting R-Type Pyocins To Generate Novel Bactericidal Protein ComplexesLacrimal Canaliculitis Due to Candida Albicans*Candida endocarditisDisseminated, Fatal, Postpartum Candidiasis with Renal Suppuration: Case ReportPATHOGENESIS OF CANDIDA ALBICANS INFECTION FOLLOWING ANTIBIOTIC THERAPY IIIPATHOGENESIS OF CANDIDA ALBICANS INFECTION FOLLOWING ANTIBIOTIC THERAPY I 1 October 1951Volume 35, Issue 4Page: 763-770KeywordsBacteriaChemotherapyDrugsHistory of medicineInfectious diseasesMouthRadiobiology ePublished: 1 December 2008 Issue Published: 1 October 1951 Copyright & PermissionsCopyright, 1951, by The American College of PhysiciansPDF downloadLoading ...